IBDEI04B ; ; 20-MAY-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;OCT 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,1676,1,4,0)
 ;;=4^369.4
 ;;^UTILITY(U,$J,358.3,1676,1,5,0)
 ;;=5^Legal Blindness-USA Def
 ;;^UTILITY(U,$J,358.3,1676,2)
 ;;=^268887
 ;;^UTILITY(U,$J,358.3,1677,0)
 ;;=369.00^^11^139^1
 ;;^UTILITY(U,$J,358.3,1677,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1677,1,4,0)
 ;;=4^369.00
 ;;^UTILITY(U,$J,358.3,1677,1,5,0)
 ;;=5^Blind,Both Eyes-WHO Def
 ;;^UTILITY(U,$J,358.3,1677,2)
 ;;=^15310
 ;;^UTILITY(U,$J,358.3,1678,0)
 ;;=369.10^^11^139^3
 ;;^UTILITY(U,$J,358.3,1678,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1678,1,4,0)
 ;;=4^369.10
 ;;^UTILITY(U,$J,358.3,1678,1,5,0)
 ;;=5^Blindness/Low Vision
 ;;^UTILITY(U,$J,358.3,1678,2)
 ;;=^268870
 ;;^UTILITY(U,$J,358.3,1679,0)
 ;;=369.20^^11^139^5
 ;;^UTILITY(U,$J,358.3,1679,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1679,1,4,0)
 ;;=4^369.20
 ;;^UTILITY(U,$J,358.3,1679,1,5,0)
 ;;=5^Low Vision,Both Eyes NOS
 ;;^UTILITY(U,$J,358.3,1679,2)
 ;;=^71924
 ;;^UTILITY(U,$J,358.3,1680,0)
 ;;=369.3^^11^139^2
 ;;^UTILITY(U,$J,358.3,1680,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1680,1,4,0)
 ;;=4^369.3
 ;;^UTILITY(U,$J,358.3,1680,1,5,0)
 ;;=5^Blindness,Both Eyes NOS
 ;;^UTILITY(U,$J,358.3,1680,2)
 ;;=^268886
 ;;^UTILITY(U,$J,358.3,1681,0)
 ;;=433.21^^11^140^10
 ;;^UTILITY(U,$J,358.3,1681,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1681,1,4,0)
 ;;=4^433.21
 ;;^UTILITY(U,$J,358.3,1681,1,5,0)
 ;;=5^Occl&Sten/Vert Art w/ Crb Inf
 ;;^UTILITY(U,$J,358.3,1681,2)
 ;;=^295732
 ;;^UTILITY(U,$J,358.3,1682,0)
 ;;=433.20^^11^140^11
 ;;^UTILITY(U,$J,358.3,1682,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1682,1,4,0)
 ;;=4^433.20
 ;;^UTILITY(U,$J,358.3,1682,1,5,0)
 ;;=5^Occl&Sten/Vert Art w/o Crb Inf
 ;;^UTILITY(U,$J,358.3,1682,2)
 ;;=^295802
 ;;^UTILITY(U,$J,358.3,1683,0)
 ;;=443.1^^11^140^12
 ;;^UTILITY(U,$J,358.3,1683,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1683,1,4,0)
 ;;=4^443.1
 ;;^UTILITY(U,$J,358.3,1683,1,5,0)
 ;;=5^Thromboangitis Obliterans
 ;;^UTILITY(U,$J,358.3,1683,2)
 ;;=^118944
 ;;^UTILITY(U,$J,358.3,1684,0)
 ;;=438.89^^11^140^2
 ;;^UTILITY(U,$J,358.3,1684,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1684,1,4,0)
 ;;=4^438.89
 ;;^UTILITY(U,$J,358.3,1684,1,5,0)
 ;;=5^Late Eff Cereb Dis NEC
 ;;^UTILITY(U,$J,358.3,1684,2)
 ;;=^317924
 ;;^UTILITY(U,$J,358.3,1685,0)
 ;;=438.11^^11^140^3
 ;;^UTILITY(U,$J,358.3,1685,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1685,1,4,0)
 ;;=4^438.11
 ;;^UTILITY(U,$J,358.3,1685,1,5,0)
 ;;=5^Late Effect CVA,Aphasia
 ;;^UTILITY(U,$J,358.3,1685,2)
 ;;=^317907
 ;;^UTILITY(U,$J,358.3,1686,0)
 ;;=438.12^^11^140^4
 ;;^UTILITY(U,$J,358.3,1686,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1686,1,4,0)
 ;;=4^438.12
 ;;^UTILITY(U,$J,358.3,1686,1,5,0)
 ;;=5^Late Effect CVA,Dysphasia
 ;;^UTILITY(U,$J,358.3,1686,2)
 ;;=^317908
 ;;^UTILITY(U,$J,358.3,1687,0)
 ;;=438.21^^11^140^5
 ;;^UTILITY(U,$J,358.3,1687,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1687,1,4,0)
 ;;=4^438.21
 ;;^UTILITY(U,$J,358.3,1687,1,5,0)
 ;;=5^Late Effect CVA,Hemipl,Dom Side
 ;;^UTILITY(U,$J,358.3,1687,2)
 ;;=^317911
 ;;^UTILITY(U,$J,358.3,1688,0)
 ;;=438.22^^11^140^6
 ;;^UTILITY(U,$J,358.3,1688,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1688,1,4,0)
 ;;=4^438.22
 ;;^UTILITY(U,$J,358.3,1688,1,5,0)
 ;;=5^Late Effect CVA,Hemipl,Non-Dom Side
 ;;^UTILITY(U,$J,358.3,1688,2)
 ;;=^317912
 ;;^UTILITY(U,$J,358.3,1689,0)
 ;;=438.32^^11^140^9
 ;;^UTILITY(U,$J,358.3,1689,1,0)
 ;;=^358.31IA^5^2
 ;;^UTILITY(U,$J,358.3,1689,1,4,0)
 ;;=4^438.32
 ;;^UTILITY(U,$J,358.3,1689,1,5,0)
 ;;=5^Late Effect CVA,Monopl,U/L,Non-Dom Side
 ;;^UTILITY(U,$J,358.3,1689,2)
 ;;=^317915
 ;;^UTILITY(U,$J,358.3,1690,0)
 ;;=438.41^^11^140^7
